Xtx Topco LTD Alzamend Neuro, Inc. Transaction History

Xtx Topco LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.19 - $0.52 $2,465 - $6,746	12,974 New	12,974 $3,000
Q1 2022 May 13, 2022	SELL	$0.91 - $2.23 $10,131 - $24,828	-11,134 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$1.9 - $3.08 $21,154 - $34,292	11,134 New	11,134 $21,000

Ticker ALZN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 95,481,800
Market Cap $159M
Description
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001 that is in Phase II clinical trial, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment ...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.